Droxia 400 MG capsule 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F20HN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,373
Award facts
- Contract value 100% obligated
- $16,372.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $16,372.66, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a contract for 60 capsules of Droxia 400 mg, a medication used in the treatment of sickle cell disease. The award was made on January 6, 2026, with an ultimate completion date of January 7, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through full and open competition. The Defense Logistics Agency, which manages the federal government's pharmaceutical supply chain for military and veteran healthcare systems, served as the funding federal agency. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate headquarters.
This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. This prime IDC enables the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The Droxia delivery exemplifies the company's role as a critical vendor fulfilling specific pharmaceutical requirements across multiple therapeutic domains for federal medical procurement needs, particularly for military treatment facilities and veterans' healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F20HN?
SPE2DR26F20HN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F20HN worth?
The government has obligated $16,373 on SPE2DR26F20HN.
Is contract SPE2DR26F20HN an order under another contract?
Yes. SPE2DR26F20HN is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20HN competed?
The extent of competition for SPE2DR26F20HN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award